Sponsor content
1 result(s) found, displaying 1 to 1
-
Australian public assessment report (AusPar)BIMZELX (bimekizumab) for treatment of moderate to severe plaque psoriasis in adult patients .
UCB PHARMA
Regulatory activities for this sponsor.